Profile data is unavailable for this security.
About the company
GB Sciences, Inc. is a biopharmaceutical research and development company. The Company develops disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its wholly owned subsidiary, GbS Global Biopharma, Inc. (GBSGB). The Company's primary focus is on preparing its lead program for the treatment of the motor symptoms of Parkinson's disease (PD) in a human clinical trial. Through GBSGB, the Company is engaged in the research and development of plant-inspired medicines, with virtual operations in North America and Europe. GBSGB has a portfolio of intellectual property containing both plant-inspired formulations and its artificial intelligence (AI)-enabled drug discovery platform, as well as research contracts and various supplier arrangements. GBSGBs intellectual property covers a range of over 65 medical conditions, from which five drug development programs are in the preclinical stage of drug development.
- Revenue in USD (TTM)0.00
- Net income in USD-4.03m
- Incorporated2018
- Employees3.00
- LocationGB Sciences Inc6450 Cameron St Ste 110ALAS VEGAS 89118-4337United StatesUSA
- Phone+1 (888) 895-3594
- Websitehttps://gbsciences.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agile Therapeutics Inc | 19.59m | -14.47m | 2.51m | 19.00 | -- | -- | -- | 0.128 | -9.84 | -9.84 | 9.11 | -5.51 | 1.60 | 4.41 | 5.79 | 1,031,158.00 | -118.12 | -94.24 | -- | -142.62 | 54.18 | -- | -73.85 | -513.50 | 0.3269 | -- | -- | -- | 80.02 | -- | 43.08 | -- | -- | -- |
| Windtree Therapeutics Inc | 0.00 | -20.29m | 2.52m | 15.00 | -- | 8.74 | -- | -- | -8.21 | -8.21 | 0.00 | 0.5655 | 0.00 | -- | -- | 0.00 | -57.68 | -44.51 | -63.50 | -48.38 | -- | -- | -- | -94,533.34 | -- | -- | 0.8179 | -- | -- | -- | 48.25 | -- | -- | -- |
| Qrons Inc | 0.00 | -789.36k | 2.53m | 2.00 | -- | -- | -- | -- | -0.0581 | -0.0581 | 0.00 | -0.109 | 0.00 | -- | -- | 0.00 | -45,235.53 | -1,513.45 | -- | -- | -- | -- | -- | -- | -- | -5.76 | -- | -- | -- | -- | -7.61 | -- | -- | -- |
| American Green Inc | -100.00bn | -100.00bn | 2.57m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| DSwiss Inc | 1.47m | -49.54k | 2.59m | 11.00 | -- | 45.84 | 157.51 | 1.76 | -0.0002 | -0.0002 | 0.0071 | 0.0003 | 3.92 | 154.82 | 54.81 | 133,643.60 | -13.22 | -8.69 | -50.26 | -45.47 | 24.44 | 25.55 | -3.37 | -2.47 | 1.05 | -15.74 | 0.3961 | -- | -20.50 | 46.20 | -688.36 | -- | -66.17 | -- |
| Virpax Pharmaceuticals Inc | 0.00 | -15.19m | 2.62m | 7.00 | -- | 1.36 | -- | -- | -12.97 | -12.97 | 0.00 | 1.65 | 0.00 | -- | -- | 0.00 | -103.68 | -87.52 | -164.09 | -116.56 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 29.84 | -- | -- | -- |
| cbdMD Inc | 23.45m | -23.98m | 2.62m | 52.00 | -- | 0.9759 | -- | 0.112 | -20.34 | -20.34 | 12.19 | 0.8839 | 0.9227 | 2.06 | 23.44 | 450,876.20 | -78.62 | -38.59 | -101.68 | -41.50 | 63.84 | 63.80 | -85.21 | -87.98 | 0.6383 | -9.92 | 0.00 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
| GB Sciences Inc | 0.00 | -4.03m | 2.64m | 3.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0119 | 0.00 | -- | -- | 0.00 | -255.86 | -49.16 | -- | -131.40 | -- | 6.03 | -- | -995.19 | -- | -8.63 | -- | -- | -- | -- | -2,715.25 | -- | -60.82 | -- |
| SYBLEU Inc | 11.70k | -307.88k | 2.68m | -- | -- | -- | -- | 229.39 | -0.0293 | -0.0293 | 0.0011 | -0.0367 | 0.0641 | -- | -- | -- | -168.63 | -- | -- | -- | -- | -- | -2,631.45 | -- | -- | -8.48 | 4.96 | -- | 0.00 | -- | 26.51 | -- | -- | -- |
| Regen BioPharma Inc | 236.58k | -851.69k | 2.72m | 1.00 | -- | -- | -- | 11.48 | -0.2271 | -0.2271 | 0.0633 | -1.26 | 0.8644 | -- | 3.98 | 236,580.00 | -327.54 | -104.36 | -- | -- | -- | -- | -378.93 | -275.00 | -- | -1.32 | -- | -- | 0.4416 | 18.79 | -58.11 | -- | -- | -- |
| Aridis Pharmaceuticals Inc | 22.36m | -1.14m | 2.74m | 37.00 | -- | -- | -- | 0.1226 | -0.1845 | -0.1845 | 0.7074 | -0.2648 | 2.40 | -- | 58.45 | 604,297.30 | -12.24 | -120.16 | -- | -678.29 | -- | -- | -5.11 | -1,559.63 | -- | -- | -- | -- | 101.37 | 29.16 | 34.43 | -- | -34.84 | -- |
| Onconetix Inc | 58.47k | -37.41m | 2.76m | 12.00 | -- | -- | -- | 47.16 | -2.09 | -2.09 | 0.0034 | 2.63 | 0.001 | -- | 0.6301 | 4,872.50 | -65.73 | -- | -87.29 | -- | -1,927.76 | -- | -63,981.00 | -- | 0.3185 | -19.88 | 0.1292 | -- | -- | -- | -176.78 | -- | -- | -- |
| Twinlab Consolidated Holdings Inc | 13.62m | -9.66m | 2.79m | 17.00 | -- | -- | -- | 0.2045 | -0.0373 | -0.0529 | 0.0526 | -0.5366 | 0.9106 | 1.34 | 4.41 | 801,000.00 | -64.61 | -60.53 | -- | -- | 36.81 | 21.36 | -70.96 | -37.72 | 0.0157 | -0.0516 | -- | -- | -20.87 | -28.58 | -20.28 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.38m | -8.02m | 2.80m | 40.00 | -- | -- | -- | 1.17 | -0.4882 | -0.4882 | 0.145 | -0.4699 | 0.1273 | 1.53 | 10.15 | 59,624.00 | -42.78 | -69.04 | -543.23 | -225.03 | -171.48 | -181.62 | -336.08 | -505.41 | 0.0331 | -2.09 | 3.29 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| Novelstem International Corp | 12.00k | -4.19m | 2.81m | 15.00 | -- | -- | -- | 234.41 | -0.0893 | -0.0893 | 0.0003 | -0.0416 | 0.0053 | -- | 2.00 | -- | -171.11 | -- | -188.15 | -- | -- | -- | -32,373.50 | -- | -- | -9.82 | 2.20 | -- | 0.00 | -- | -446.84 | -- | -- | -- |
